Skip to content

Prospective Randomized Controlled Trials on Clinical Outcomes of Indocyanine Green Tracer Using in Esophagectomy for Esophagus Cancer

Prospective Randomized Controlled Trials on Clinical Outcomes of Indocyanine Green Tracer Using in Esophagectomy for Esophagus Cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044978
Enrollment
Unknown
Registered
2021-04-03
Start date
2021-04-02
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophagus cancer

Interventions

ICG group:Indocyanine green imaging
Non-ICG group:Conventional treatment

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.18 years old < age < 80 years old; 2.The primary lesion of the esophagus was diagnosed as esophageal cancer by endoscopic biopsy histopathology; 3.No distant metastasis was observed in preoperative examination, and no tumor directly invaded adjacent organs; 4.The preoperative ECOG physical status score was 0/1; 5.Preoperative ASA score I-III; 6.Informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. suffer from serious mental illness; 3. A history of other malignant diseases within 5 years; 4. A history of unstable angina or myocardial infarction within 6 months; 5. A history of cerebral infarction or cerebral hemorrhage within 6 months; 6. A history of continuous systemic corticosteroid therapy within 1 month; 7. Concurrent surgical treatment for other diseases; 8. Previous history of allergy to indoleqing green drug; 9. Patients who are unable to cooperate with the study due to psychological, family or social reasons and refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Anastomotic leakage;postoperative voice hoarse;Postoperative pneumonia;Secondary surgery;Thoracic drainage;Abdominal discharge;Postoperative arrhythmia;Postoperative albumin;

Secondary

MeasureTime frame
postoperative hospital stay;ICU stay;

Countries

China

Contacts

Public ContactMingqiang Kang

Fujian Union Hospital

Mingqiang_kang@163.com+86 13365910323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026